Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Candida dubliniensis is a recently described species that has been shown to cause oropharyngeal candidiasis in patients with HIV. We present a detailed evaluation of a patient undergoing head and neck radiation for oral cancer who developed oropharyngeal candidiasis from a mixed infection of C dubliniensis and Candida albicans. To our knowledge, this is the first described case of C dubliniensis contributing to oropharyngeal candidiasis in this patient population.
Redding
S W
SW
Department of General Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, Tex 78229-3900, USA. redding@uthscsa.edu
Bailey
C W
CW
Lopez-Ribot
J L
JL
Kirkpatrick
W R
WR
Fothergill
A W
AW
Rinaldi
M G
MG
Patterson
T F
TF
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002175:Candida / Q000145:classification* / Q000235:genetics / Q000254:growth & development; D002176:Candida albicans / Q000254:growth & development; D002177:Candidiasis / Q000382:microbiology*; D002180:Candidiasis, Oral / Q000382:microbiology*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy* / Q000556:secondary; D002863:Chromogenic Compounds; D004271:DNA, Fungal / Q000032:analysis; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D006801:Humans; D007621:Karyotyping; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D009062:Mouth Neoplasms / Q000532:radiotherapy*; D009960:Oropharynx / Q000382:microbiology*; D010608:Pharyngeal Diseases / Q000382:microbiology*; D011832:Radiation Injuries / Q000382:microbiology*
D000935:Antifungal Agents; D002863:Chromogenic Compounds; D004271:DNA, Fungal; D015725:Fluconazole